Synthekine
Synthekine is a company applying distinct protein engineering platforms to develop selective cytokine therapeutics for cancer and inflammatory disease.
Last updated September 15, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Synthekine is a company based in Menlo Park, United States. It applies distinct protein engineering platforms to develop immunotherapies designed to unlock the full efficacy potential of cytokines while avoiding toxicities associated with their pleiotropy. The company is focused on discovering, developing and commercializing the next generation of selective cytokine therapeutics, based on the belief that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
History
Synthekine is a company located in Menlo Park, United States. It applies distinct protein engineering platforms to develop immunotherapies designed to unlock the full efficacy potential of cytokines while avoiding toxicities associated with their pleiotropy. The company describes its work as discovering, developing and commercializing the next generation of selective cytokine therapeutics, and states its belief that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
Products and positioning
Selective cytokine therapeutics engineered to change the treatment paradigm of cancer and inflammatory disease.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/synthekine · Editorial policy · How profiles are compiled